The Structure of the NPC1L1 N-Terminal Domain in a Closed Conformation.
Kwon, H.J., Palnitkar, M., Deisenhofer, J.(2011) PLoS One 6: e18722-e18722
- PubMed: 21525977 
- DOI: https://doi.org/10.1371/journal.pone.0018722
- Primary Citation of Related Structures:  
3QNT - PubMed Abstract: 
NPC1L1 is the molecular target of the cholesterol lowering drug Ezetimibe and mediates the intestinal absorption of cholesterol. Inhibition or deletion of NPC1L1 reduces intestinal cholesterol absorption, resulting in reduction of plasma cholesterol levels.
Organizational Affiliation: 
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. hyockjoo.kwon@gmail.com